Publication Name	World Journal of Transplantation
Manuscript ID	2795
Country	United States

Received	2013-03-15 09:35
Peer-Review Started	2013-03-15 20:16
To Make the First Decision	2013-04-16 09:20
Return for Revision	2013-05-09 17:54
Revised
Second Decision	2013-07-18 15:15
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-07-19 03:53
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-09-29 23:28
Publish the Manuscript Online	2013-12-31 17:17

ISSN	2220-3230 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Autobiography
Article Title	Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center
Manuscript Source	Invited Manuscript
All Author List	Ibtesam A Hilmi, Raymond M Planinsic, Ramona Nicolau-Raducu, Daniela Damian, Ali Al-Khafaji, Tetsuro Sakai and Kareem Abu-Elmagd
Funding Agency and Grant Number	Funding Agency Grant Number Department of Anesthesiology at the University of Pittsburgh Medical Center
Corresponding Author	Ibtesam A Hilmi, MBCHB, FRCA, Associate Professor of Anesthesiology, Department of Anesthesiology, University of Pittsburgh Medical Center, Presbyterian Hospital, C-wing Suite 200,200 Lothrop St., Pittsburgh, PA 15213, United States. hilmiia@anes.upmc.edu
Key Words	Small bowel transplant; Outcomes; Immune induction agents; Zenapax; Thymoglobulin; Campath
Core Tip	Core tip: Small bowel transplant (SBTx) is the treatment of choice for patients with intestinal failure. However, patient and graft survival can be affected by multiple factors, such as the choice of immunosuppressant and immune induction agent. Studying the effects of these agents may help care providers customize the immunosuppressant protocol to the individual patient. In this study, we reviewed in great detail how different immune induction agents can impact the intraoperative and postoperative course, as well as the short term outcome of these patients. Such information can be of great value to physicians who treat SBTx recipients.
Publish Date	2013-12-31 17:17
Citation	Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakai T, Abu-Elmagd K. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant 2013; 3(4): 127-133
URL	http://www.wjgnet.com/2220-3230/full/v3/i4/127.htm
DOI	http://dx.doi.org/10.5500/wjt.v3.i4.127

Full Article (PDF)	WJT-3-127.pdf
Full Article (Word)	WJT-3-127.doc
Manuscript File	2795-edited.docx
Peer-review Report	2795-Peer review(s).pdf
Scientific Editor Work List	2795-Scientific editor work list.doc